Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 11, 2009, Pages 4559-4565

  Murugan, Venkatesh ^a   Mukherjee, Kakali ^a   Maiti, Kuntal ^a   Mukherjee, Pulok K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Antioxidant; Carbon tetrachloride; Ellagic acid; Hepatoprotective activity; Pharmacokinetic; Phospholipid complex

Indexed keywords

ANTIOXIDANT; CATALASE; ELLAGIC ACID; GLUTATHIONE; PHOSPHOLIPID; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; LIVER; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; RAT; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CATALASE; ELLAGIC ACID; GLUTATHIONE; LIVER; MALE; OXIDATIVE STRESS; PHOSPHOLIPIDS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 67149084707     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8037105     Document Type: Article

References (45)

1. Wong, S. M.; Kellaway, 1. W.; Murdan, S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. tot J. Pharm. 2006, 317, 61-68.
2. Naseem, A.; Olliff, C. J.; Martini, L. G.; Lloyd, A. W. Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin. Int. J. Pharm. 2004, 269, 443-450.
3. Amakura, Y.; Okada, M.; Tsuji, A.; Tonogai, Y. High performance liquid chromatography determination with photodiode array detection of ellagic acid in fresh and processed fruits. J. Chrotnatogr., B 2000, 896, 87-93.
4. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavail-ability. Pharm. Res. 1995, 12, 413-420.
5. Bala, V.; Bhardwaj, S.; Hariharan, S. V.; Kharade, N.; Kumar, M. N. V. R. Sustained release nanoparticulate formulation containing antioxidant ellagic acid as potential prophylaxis system for oral administration. J. Drug Target. 2006, 14, 27-34.
6. Bala, V.; Bhardwaj, S.; Hariharan, S. V.; Kumar, M. N. V. R. Analytical methods for assay of ellagic acid and its solubility studies. J. Pharm. Biomed. Anal. 2006, 40, 206-210.
7. Doyle, B.; Griffiths, L. A. The metabolism of ellagic acid in the rat. Xenobiotica. 1980, 10, 247-256.
8. Teel, R. W. Distribution and metabolism of ellagic acid in the mouse following intraperitoneal administration. Cancer Lett. 1987, 34, 165-171.
9. Smart, R. C.; Huang, M. T.; Chang, R. L. Disposition of natural occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-dodecylellagic acid and 3,3-di-o-methyl ellagic acid in mice. Carcinogenesis 1986, 7, 1663-1667.
10. Lei, F.; Xing, D.; Xiang, L.; Zhao, Y.; Wang, W. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J. Chromatogr., B 2003, 796, 189-194.
11. Priyadarsini, I. K.; Khopde, S. M.; Kumar, S. S.; Mohan, H. J. Free radical studies of ellagic acid, a natural phenolic antioxidant. J. Agric. Food Chem. 2002, 50, 2200-2206.
12. Lino, T.; Tashima, K.; Umeda, M.; Ogawa, Y.; Takeeda, M.; Takata, K.; Takeuchi, K. Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion. J. Life Sci. 2002, 70, 1139-1150.
13. Zhang, Z.; Hamilton, S. M.; Stewart, C.; Strother, A.; Teel, R. W. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 1993, 13, 2341-2346.
14. Aidoo, K. E.; Hendry, R.; Wood, B. J. B. Solid state fermentation. Adv. Appl. Microhiol. 1982, 28, 201-237.
15. Hassoun, E. A.; Walter, A. C.; Alsharif, N. Z.; Stohs, S. J. Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. Toxicol. 1997, 124, 27-37.
16. Devipriya, N.; Srinivasan, M.; Sudheer, A. R.; Menon, V. P. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study. Singapore Med. J. 2007, 48, 311-318.
17. Maiti, K.; Mukherjee, K.; Gantait, A.; Ahamed, K. F. H.; Saha, B. P.; Mukherjee, P. K. Enhanced therapeutic benefit of quercetin-phos-pholipid complex in carbon tetrachloride-induced acute liver injury in rats: a comparative study. Iranian J. Pharmacol. Ther. 2005, 4, 84-90.
18. Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B. P.; Mukherjee, P. K. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J. Pharm. Pharmacol. 2006, 58, 1227-1233.
19. Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B. P.; Mukherjee, P. K. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330, 155-163.
20. Lei, F.; Xing, D.; Xiang, L.; Zhao, Y.; Wang, W.; Zhang, L.; Du, L. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J. Chromatogr., B 2003, 796, 189-194.
21. Gary, D. S.; Sardo, C.; Apseloff, G.; Mullet, D.; Wargo, W.; Pound, V.; Singh, A.; Sanders, J.; Aziz, R.; Casto, B.; Sun, X. Pharmaco-kinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J. Clin. Pharmacol. 2005, 45, 1153-1164.
22. Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophvs. 1959, 82, 70-77.
23. Paglia, D. E.; Valentine, W. N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70, 158-169.
24. Habig, W. H.; Pabst, M. J.; Jakoby, W. B. The glutathione S-transferases; the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139.
25. Dubler, R. E.; Anderson, B. M. Simultaneous inactivation of the catalytic activities of yeast glutathione reducase by N-alkyl melei-mimdes. Biochim. Biophys. Acta 1981, 659, 70-85.
26. Kakkar, B.; Das, P. N.; Viswanathan, A. Modified spectrophoto-meter assay of SOD. Ind. J. Biochem. Biophvs. 1984, 21, 130-132.
27. Beer, R. F.; Seizer, T. W. A spectrophotometric method for measuring breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 115, 130-140.
28. Maechlay, A. C.; Chance, B. The assay of catalase and peroxidase. In Methods of Biochemical Analysis. Glick, D., Ed.; Interscience: New York, 1954; pp 357-424.
29. Ohkawa, H.; Hash, N.; Yagi, K. Assay for lipid peroxide for animal tissue by thiobarbituric acid reaction. Ann. Biochem. 1979, 95, 351-358.
30. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
31. Reitman, S.; Frankel, S. Colorimetric method for the determination of SGOT and SGPT. Am. J. Clin. Pathol. 1957, 28, 56-63.
32. Kind, P. R. N.; King, E. J. J. Estimation of plasma phosphatase by determination of hydrolysed phenol with aminopyrines. J. Clim. Pathol. 1954, 7, 332-336.
33. Malloy, H. T.; Evelyn, K. A. The determination of bilirubin with the photoelectric colorimeter. J. Biol. Chem. 1937, 119, 481-490.
34. Antony, B.; Merina, B.; Iyer, V. S.; Judy, N.; Lennertz, K.; Joyal, S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95® CG (Biocurcumax™), a novel bioenhanced preparation of curcumin. Ind. J. Pharm. Sci. 2008, 70, 445-449.
35. Shahrzad, S.; Aoyagi, K.; Winter, A.; Koyama, A.; Bitsch, I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr. 2001, 131, 1207-1210.
36. Mukherjee, P. K. Evaluation of Indian traditional medicine. Drug Inf. J. 2001, 35, 623-632.
37. Mukherjee, P. K. Problems and prospects for the GMP in herbal drugs in Indian systems of medicine. Drug Inf. J. 2002, 63, 635-644.
38. Mukherjee, P. K. Plant products with hypocholesterolemic potentials. In Advances in Food and Nutrition Research; Taylor, S. L., Ed.; Elsevier Academic Press: New York, 2003; pp 277-338.
39. Mukherjee, P. K. Evaluation of hepatoprotective agents. In Quality Control of Herbal Drugs - An Approach to Evaluation of Botanicals; Business Horizons: New Delhi, India, 2002; pp 529-534.
40. Rai, S.; Wahile, A.; Mukherjee, K.; Saha, B. P.; Mukherjee, P. K. Antioxidant activity of Nelumbo nucifera (sacred lotus) seeds. J. Ethnopharmacol. 2006, 104, 322-327.
41. Raja, S.; Ahamed, K. F. H. N.; Kumar, V.; Mukherjee, K.; Saha, B. P.; Bandyopadhyay, A.; Mukherjee, P. K. Cytisus scoparius link - a natural antioxidant. BMC Complement. Altern. Med. 2006, 6, 8.
42. Kim, H. J.; Bruckner, J. V.; Dallas, C. E.; Gallo, G. M. Effects of dosing vehicles on the pharmacokinetics of orally administered carbon tetrachlorides in rats. Toxicol. Appl. Pharmacol. 1990, 102, 50-60.
43. Valles, E. G.; De Castro, C. R.; De Castro, J. A. N-Acetylcysteine is an early but also a late preventive agent against carbon tetrachloride-induced liver necrosis. Toxicol. Lett. 1994, 71, 87-95.
44. Glende, E. A.; Hruszewycz, A. M.; Recknagel, R. O. Critical role of lipid peroxidation in carbon tetrachloride-induced loss of amino-pyrine demethylase, cytochrome P-450 and glucose-6-phosphatase. Biochem. Pharmacol. 1976, 25, 2163-2170.
45. Raja, S.; Ahamed, K. F. H. N.; Kumar, V.; Mukherjee, K.; Bandyopadhyay, A.; Mukherjee, P. K. Antioxidant effect of Cytisus scoparius against carbon tetrachloride treated liver injury in rats. J. Fthnopharmacol. 2007, 109, 41-47.